StageZero Life Sciences
  • About
    • Our Story
    • Board of Directors
    • Partners
    • Library
    • Programs >
      • Telehealth
      • Employers
      • Firefighters
      • Executive Health
  • Our Science
    • The Sentinel Principle
    • Aristotle
    • ColonSentry Science
    • Publications
  • Covid-19 Testing
    • Covid-19-PCR-Saliva
    • Covid-19-PCR
    • Covid-19-Antibody
    • Respiratory Panel + COVID-19
    • Covid-19-Employers
    • Covid-19-PhysicianEnrollment
    • Frequently Asked Questions
  • Cancer Testing
    • ColonSentry Test
    • Prostate Health Index
    • BreastSentry
    • Purchase Tests
  • Physicians
    • Establish an Account
    • Order Supplies
    • Copia Login
  • INVESTORS
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In the News
    • Analyst Coverage
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment

I
We Are Passionate About Our Mission to Reduce The Incidence of Late Stage Cancer 
​

​
Our next-generation test, Aristotle™, is a panel for simultaneously screening for 10 cancers from a single blood sample. Aristotle was recently selected for online publication at the 2020 annual meeting of the American Society of Clinical Oncology. 
​

​(TSX:SZLS)
​
Follow Us on Social Media!

Stock Chart
​Press Releases
SEDAR Filings
​Corporate Governance

Shareholder Information
Events




Investor Relations

We are ​StageZero Life Sciences (TSX: SZLS) and we are dedicated to finding cancer in the earliest stages when it is most curable. Our next-generation test, Aristotle™, is a panel for simultaneously screening for 10 cancers from a single blood sample.  Aristotle has been built on the company's mRNA Sentinel Principle Technology Platform, which was used to develop one of the first commercially available blood tests for Colorectal Cancer, ColonSentry®.

Latest News


Investor Relations Contacts
James R. Howard-Tripp 
Chairman and CEO
jht@stagezerols.com

Rebecca Greco
Investor Relations

rgreco@stagezerols.com 
​1-855-420-7140 ext 1838

Corporate Headquarters
​30-70 East Beaver Creek Road

Richmond Hill, ON L4B 3B2

contact@stagezerols.com

Stay In Touch! Subscribe to Our Investor Updates

Picture
30-70 East Beaver Creek Road
Richmond Hill, Ontario L4B 3B2

8751 Park Central Drive, Suite 200
Richmond, VA 23227
​TEL: 855.420.7140 
Contact Information

Notice of Privacy Practices | Terms & Conditions | Privacy Statement & Policy | Licensing & Accreditation
  • About
    • Our Story
    • Board of Directors
    • Partners
    • Library
    • Programs >
      • Telehealth
      • Employers
      • Firefighters
      • Executive Health
  • Our Science
    • The Sentinel Principle
    • Aristotle
    • ColonSentry Science
    • Publications
  • Covid-19 Testing
    • Covid-19-PCR-Saliva
    • Covid-19-PCR
    • Covid-19-Antibody
    • Respiratory Panel + COVID-19
    • Covid-19-Employers
    • Covid-19-PhysicianEnrollment
    • Frequently Asked Questions
  • Cancer Testing
    • ColonSentry Test
    • Prostate Health Index
    • BreastSentry
    • Purchase Tests
  • Physicians
    • Establish an Account
    • Order Supplies
    • Copia Login
  • INVESTORS
    • Investor Relations
    • Press Releases
    • Investor FAQs
    • Events
    • In the News
    • Analyst Coverage
  • Contact
    • Customer Support
    • Corporate HQ
    • Careers
    • Bill Payment